MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort.

Journal of the National Cancer Center · 2024-02-02

JNCI Journal of the National Cancer Institute · 1998-09-16

CA A Cancer Journal for Clinicians · 2011-02-04

arXiv · 2020-02-18